The agency declined to evaluate three of them, writing that the nominations did not include sufficient information and that it did not identify clinical studies using BPC-157 in these populations. The 68-page review is entirely about ulcerative colitis, because thats the only proposed use with any human trial behind it
A practitioner asking should I offer MIC? in 2026 is implicitly asking why would I, when I can prescribe a GLP-1? The honest answers are narrower than the marketing, but they are real: Patients who cannot or will not take a GLP-1
The peptide's presence in nearly every cell type hints at its fundamental biological importance
Meanwhile, new formats are coming to market, including skin patches and nasal sprays
By improving sleep patterns, DSIP helps your muscles and tissues recover more efficiently, leaving you refreshed and ready for peak performance every day